Sporadic Burkitt’s lymphoma presents as an isolated orbital disease

Ana Ibáñez Muñoz, Ana Ibáñez Muñoz, Ana Ibáñez Muñoz, M. Ester Lizuain Abadia, M. Ester Lizuain Abadia, Elena Delso Gil, Elena Delso Gil, Sara Velilla Osés, Sara Velilla Osés

Abstract


Burkitt’s lymphoma is a highly aggressive non–Hodgkin’s lymphoma and the fastest growing, that accounts for 3% to 5% of all lymphomas.  Three clinically subtypes have been described:  endemic, sporadic, and immunodeficiency-associated.  The sporadic form typically presents as an abdominal mass.  Orbital involvement has rarely been reported.  In this case report, a 66-year-old man presented with a three-week history of vision loss and painful proptosis of the left eye.  Neuro-imaging revealed a well-circumscribed solid mass of the left orbit, for which a biopsy under general anesthesia was performed.   The diagnosis of Burkitt’s lymphoma was confirmed by immunohistochemistry.  Chemotherapy was initiated with good clinical outcome, though there was no improvement in his visual acuity.  In conclusion, Burkitt’s lymphoma must be considered in patients who present with painful proptosis and vision loss, as it is one of the fastest growing and chemosensitive malignancies, which can lead to irreversible vision loss.


References


Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46: 218-223.

Harris N, Jaffe E, Diebold J, et al. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-49.

Rainey JJ, Omenah D, Sumba PO, et al. Spatial clustering of endemic Burkitt’s lymphoma in high-risk regions of Kenya. Int J Cancer 2007; 120: 121-7.

Baker PS, Gold KG, Lane KA, et al. Orbital Burkitt lymphoma in immunocompetent patients: a report of 3 cases and a review of the literature. Ophthal Plast Reconstr Surg 2009; 25: 464-468.

Davi F, Delecluse H, Guiet P, et al. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. J Clin Oncol 1998; 16: 3788-95.

Shad A, Magrath I. Non-Hodgkin’s lymphoma. Pediatr Clin North Am 1997; 44: 863-90.

Alexander C, George C, Tinatin J, et al. Orbital Burkitt lymphoma: a case presentation. BMC Ophthalmol 2014; 14(109): 1-4.

Bouali S, Said IB, Yedeas MD, et al. Promary sporadic Burkitt lymphoma of the orbit, clinical characteristics, management, and outcomes: a case study. Childs Nerv Syst 2016; 32(3):437-40.

de Freytas A, Rengel Ruiz M, Espana Gregori E. Proptosis as initial manifestation of Burkitt’s lymphoma with orbital involvement, Arch Soc Esp Oftalmol 2017; 92(4): 178-180.

Harris N, Jaffe E, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.

Bowman W, Shuster J, Cook B, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a Pediatric Oncology Group Study. J Clin Oncol 1996; 14: 1252-61.

Hecht J, Aster J. Molecular biology of Burkitt’s lymphoma. J Clin Oncol 2000; 18: 3703-21.

Murphy S, Bowman W, Abromowitch M, et al. Results of treatment of advanced-stage Burkitt’s lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4(12): 1732-9.

Patte C, Phillip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991; 9: 123-32.

Reiter A, Schrappe M, Ludwig WD, et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 1992; 80: 2471-8.

Divine M, Casassus P, Koscielny S, et al. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol 2005; 16: 1928-35.

Todeschini G, Tecchio C, Degani D, et al. Eighty-one percent event-free survival in advanced Burkitt’s lymphoma / leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol 1997; 8: S77-S81.




DOI: http://dx.doi.org/10.16964/er.v5i1.78

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Eye Reports [eISSN 2039-4756] is a new Open Access, online-only, peer-reviewed journal.